( en | de | ru )

 

Disambiguation of "Feller, Alfred C."

Author of the publication

copydeleteadd this publication to your clipboard
Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis

, , , , , , , , , , , , , , , , , and . Haematologica, 95 (12): 2047–2055 (2010)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Alfred Christian Feller

Alfred Christian Feller

Alfred Christian Feller

Alfred C Köcher

Aron Feller

 

Other publications of authors with the same name

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL, , , , , , , , , and 3 other author(s). Blood, 104 (3): 634–641 (2004)A biological definition of Burkitt's Lymphoma from transcriptional and genomic profiling, , , , , , , , , and 25 other author(s). The New England Journal of Medicine, 354 (23): 2419--2430 (2006)Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials, , , , , , , , , and 10 other author(s). Haematologica, 94 (11): 1569–1580 (2009)Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL, , , , , , , , , and 12 other author(s). Blood, 116 (23): 4916–4925 (2010)MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma, , , , , , , , , and 10 other author(s). Blood, 121 (12): 2253–2263 (2013)A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling, , , , , , , , , and 25 other author(s). The New England journal of medicine, 354 (23): 2419–2430 (2006)Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status, , , , , , , , , and 18 other author(s). Genes, chromosomes & cancer, 48 (1): 39–54 (2009)MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas, , , , , , , , , and 5 other author(s). British journal of haematology, 142 (5): 732–744 (2008)Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60), , , , , , , , , and 16 other author(s). The Lancet Oncology, 9 (2): 105–116 (2008)Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis, , , , , , , , , and 8 other author(s). Haematologica, 95 (12): 2047–2055 (2010)